Companies / Century Therapeutics, Inc. / Activity
Activity — Century Therapeutics, Inc.
8 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q1 2026 as of | Bank of New York Mellon Corp/The 13F manager | New | Common Stock | $29.1K | +13K | 12,897 <0.01% of shares | low |
| Q2 2026 as of | Victory Capital Management, Inc. 13F manager | New | Common Stock | $34.5K | +14K | 14,101 <0.01% of shares | low |
| Q1 2026 as of | OMERS Administration Corporation 13F manager | New | Common Stock | $108.0K | +48K | 47,800 0.03% of shares | low |
| Q2 2026 as of | Quadrature Capital Ltd 13F manager | New | Common Stock | $112.4K | +46K | 45,890 0.03% of shares | low |
| Q2 2026 as of | Deutsche Bank AG 13F manager | New | Common Stock | $294.6K | +120K | 120,234 0.07% of shares | low |
| Q1 2026 as of | Marshall Wace, LLP 13F manager | New | Common Stock | $1.52M | +674K | 673,584 0.37% of shares | low |
| Q1 2026 as of | Balyasny Asset Management L.P. 13F manager | New | Common Stock | $11.34M | +5.0M | 5,017,733 2.77% of shares | medium |
| Q1 2026 as of | RA Capital Management, L.P. 13F manager | New | Common Stock | $40.13M | +17.8M | 17,754,430 9.80% of shares | medium |